Japanese researchers found that lecanemab, an amyloid-clearing drug for Alzheimer’s, does not improve the brain’s waste clearance system in the short term. This implies that nerve damage and impaired ...

Alzheimer's Disease (AD), the leading cause of dementia, affects nearly 40 million individuals globally, resulting in a ...

Our Top PicksBest rechargeableJabra EnhanceBest basic optionsMDHearingMost discreetEargoThe combination of hearing loss and dementia presents a unique challenge for family members and caregivers ...

The lights of the iconic Route 66 Drive-Thru Shield in downtown Kingman shined brightly in teal during the week of Nov. 3 to ...

With evidence of daily oscillations in brain cells affected by neurodegeneration, researchers can investigate ways to counter ...

A simple blood test for platelet activity at middle age could one day help identify people at risk for Alzheimer's disease ...

WPBF 25 goes "On the Record" on Alzheimer's Disease and how medical professionals are working to combat the disease.

New research has found that the loss of social memory – recognizing friends and family – in Alzheimer's disease (AD) could ...

A newly approved blood test can help rule out some cases based on the amount of amyloid in the brain. A neurology professor ...

Brisk walking might be particularly beneficial. A small trial of 15 people with mild to moderate Alzheimer’s who did Nordic ...

It is one of about 2,000 human brains to be processed into Pitt’s Neurodegenerative Brain Bank, one of the oldest. most established in the country.

Researchers say the study indicates the ability to bring the power of AI and patient-reported outcomes directly into the clinic seamlessly, affordably, and at scale.